The kappa partial agonist PPL-103 as a potential cocaine abuse pharmacotherapy
Ended Project Grant Awarded Last action
- Award ID
- R41DA044894
- Recipient
-
Phoenix Pharmalabs, Inc. UEI SK3VX5DEN6E7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $186,687
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Woods Cross, UT, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $186,687 |
Quick answers
Who received award R41DA044894?
R41DA044894 was awarded to Phoenix Pharmalabs, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2018.
How much is award R41DA044894 worth?
$186,687 has been obligated on R41DA044894.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award